The Effectiveness of Group-Delivered Guided Written Exposure Therapy for PTSD and CPTSD Among Adolescents : A Pilot Study
1 other identifier
interventional
53
1 country
1
Brief Summary
The study aims to examine the effectiveness of group-delivered guided written exposure therapy (GWE) for post-traumatic stress disorder (PTSD) and complex PTSD in Chinese adolescents through a randomized controlled trial. A total of 50 participants will be recruited, with 25 randomized to the GWE group and 25 to the waiting-list (WL) group. The GWE intervention will consist of 5 to 8 group sessions. The primary outcome, PTSD and CPTSD symptom severity, will be assessed at baseline, post-treatment, 1-month follow-up, and 3-month follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2024
CompletedFirst Posted
Study publicly available on registry
May 7, 2024
CompletedStudy Start
First participant enrolled
May 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2024
CompletedApril 23, 2026
May 1, 2024
5 months
May 3, 2024
April 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
PTSD Checklist-5 (PCL-5)
PCL-5 was a 20-item self-report scale that assesses PTSD DSM-5 diagnosis and symptom severity in the past month. Items were rated on a 5-point Likert scale from 0 ("not at all") to 4("extremely").The Chinese version of PCL-5 has shown good psychometric properties in trauma-affected Chinese adolescents.
baseline, post treatment(2 weeks), 6 weeks, 14 weeks
CPTSD symptoms
CPTSD symptoms include two parts: PTSD symptoms were assessed using six PCL-5 items mapped to ICD-11 domains: re-experiencing (items 2 and 3), avoidance (items 6 and 7), and sense of current threat (items 17 and 18). Disturbances in self-organization (DSO) were measured using the 6-item DSO subscale of the International Trauma Questionnaire-Child and Adolescent Version (ITQ-CA), which has demonstrated good validity in Chinese adolescent samples. The resulting 12-item composite yielded total scores ranging from 0 to 48, consistent with ITQ-CA scoring conventions.
baseline,post treatment(2 weeks), 6 weeks, 14 weeks
Secondary Outcomes (3)
Patient Health Questionnaire 9-item
baseline, post treatment(2 weeks), 6 weeks, 14 weeks
Generalized Anxiety Disorder 7-item
baseline, post treatment(2 weeks), 6 weeks, 14 weeks
The Strengths and Difficulties Questionnaire
baseline, post treatment(2 weeks), 6 weeks, 14 weeks
Study Arms (2)
GWE
EXPERIMENTALWaiting-List (WL) condition
OTHERInterventions
Participants assigned to WL will be asked to not work with other therapists or seek additional treatment for trauma-related difficulties during the waitting period. After the one-month follow-up of the GWE group, they will receive the same treatment.WL participants will also be given contact information to use in case of worsening symptoms or increasing distress.
Group-Delivered guided written exposure therapy (GWE) is a manualized exposure-based therapy program consisting of 5-8 sequential sessions. The interval between every 2 consecutive sessions is 0-2 days. There will be 5-8 group-delivered sessions in total (only one index trauma will be discussed), and 1-2 weeks to complete.The first and last sessions are scheduled to last for 1.5 hours each, while the other sessions will be 50 minutes in duration.
Eligibility Criteria
You may qualify if:
- Adolescents aged 10-18 years.
- Meeting full or subthreshold PTSD (up to one symptom missing) diagnostic criteria according to the Child PTSD Symptom Scale-Interview Version for DSM-5 (CPSS-5-I).
- If taking psychotropic medication, currently stabilized on psychotropic medication for at least four weeks.
- Capable of writing and understanding written instructions.
You may not qualify if:
- Presence of severe psychopathology necessitating immediate medical attention
- Moderate to high suicide risk (e.g., intent or plan to attempt suicide in the near future)
- Evidence of a moderate or severe traumatic brain injury
- Currently undergoing psychotherapy specifically for PTSD.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University
Beijing, Beijing Municipality, 100871, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Randomization was conducted by an independent research assistant, and the random sequence was concealed from the investigator until the process was completed.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Fellow
Study Record Dates
First Submitted
May 3, 2024
First Posted
May 7, 2024
Study Start
May 10, 2024
Primary Completion
October 15, 2024
Study Completion
October 15, 2024
Last Updated
April 23, 2026
Record last verified: 2024-05